XTL Biopharmaceuticals Ltd. (FRA:H2K2)
Germany · Delayed Price · Currency is EUR 0.6850
+0.0300 (4.58%)
At close: Jan 30, 2026
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of €6.94 million as of January 30, 2026. Its market cap has decreased by -66.55% in one year.
Market Cap
6.94M
Enterprise Value
6.78M
Revenue
824.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.69
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 144.96M to 6.94M, a decrease of -95.21%. That is a compound annual growth rate of -13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.94M | 14.42% |
| Dec 31, 2025 | 6.07M | -71.94% |
| Dec 31, 2024 | 21.62M | 351.29% |
| Dec 31, 2023 | 4.79M | -19.50% |
| Dec 29, 2022 | 5.95M | -55.04% |
| Dec 30, 2021 | 13.24M | 3.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| plenum AG | 9.51M |
| Turbon AG | 8.94M |
| AHT Syngas Technology | 8.85M |
| MedNation AG | 8.65M |
| Altech Advanced Materials AG | 7.61M |
| Bio-Gate AG | 7.54M |
| BHB Brauholding Bayern-Mitte AG | 6.63M |
| BigRep SE | 5.97M |